510(k) device
RIGHTEST Blood Glucose Monitoring System Max Tel
Bionime Corporation · System, Test, Blood Glucose, Over The Counter (NBW, Class II) · First FDA decision Jan 3, 2005, newest Nov 4, 2024Diabetes
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
14
510(k) pathway
Device trials
6
Naming "RIGHTEST"
MAUDE reports
0
Brand "RIGHTEST", since 2015
PubMed studies
10
Mentioning "RIGHTEST"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing RIGHTEST Blood Glucose Monitoring System Max Tel
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 14 decisions filed under this name.
K240637 · Decided Nov 4, 2024 · 243 days after receipt
Device type: System, Test, Blood Glucose, Over The Counter (NBW) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
Older decisions: K123008, K110737, K092052, K081451, K081450, K072054, K062567, K042678
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Blood Glucose TestingNational determinationOn the books190.20Updated Oct 1, 2026
- Lipid and Blood Glucose Testing (Modification of Code List to Implement Screening Benefit Added by Medicare Modernization Act (MMA)Coding analysisReview closedCAG-00266NUpdated Sep 14, 2026
- Home Blood Glucose MonitorsNational analysisReview closedCAG-00161NUpdated Sep 14, 2026
- Blood Glucose Testing (Revision of ICD-9-CM Codes for Osteomyelitis)Coding analysisReview closedCAG-00183NUpdated Sep 14, 2026
- Home Blood Glucose MonitorsNational determinationOn the books40.2Updated Dec 2, 2024
- Closed-Loop Blood Glucose Control Device (CBGCD)National determinationOn the books40.3Updated Apr 17, 2020
Clinical trials
Device studies on ClinicalTrials.gov that name "RIGHTEST", any status and sponsor, newest update first.
Bionime CorporationNot on our public-company list
NCT07889388 · 104 participants (planned) · Start Jun 9, 2026 · Primary completion Mar 2027
Device: RIGHTEST iFree 2 Continuous Glucose Monitoring System · For: Diabetes Mellitus, Type 1 Diabetes; Diabetes Mellitus, Type 2; Diabetes, Gestational
Sites: Ulm, Germany
5 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "RIGHTEST", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NBW
258,305 reports: 243,487 malfunction, 14,268 injury, 39 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "RIGHTEST"[tiab]. The summary above synthesizes these.
- [Jejunal biopsy].
Gobio Casali L, De Ritis G, Magazzù G, et al. · Pediatr Med Chir · 1987English Abstract
- Diabetes self-management smartphone application: Could it be an alternative for continuous glucose monitoring in low resource settings?
Elbarbary NS, Mohamed MO, Fereig YA · Prim Care Diabetes · 2025Clinical Trial
- Enhancement in the therapeutic potential of lapatinib ditosylate against breast cancer by the use of β-cyclodextrin based ternary nanosponge system.
Tanaji Mane P, Sopanrao Wakure B, Shridhar Wakte P · Int J Pharm · 2023
- Comparative Performance Analysis of Three Point-of-Care Glucose Testing Devices against a Central Laboratory Reference Method.
Ashar A, Aulia FA, Marpaung FR, et al. · EJIFCC · 2026
- Assessment Driven Integrated Learning (ADIL): Assessment Directed Medical Education (ADME) curriculum.
Khan JS · J Ayub Med Coll Abbottabad · 2010
- System accuracy evaluation of 18 CE-marked current-generation blood glucose monitoring systems based on EN ISO 15197:2015.
Pleus S, Baumstark A, Jendrike N, et al. · BMJ Open Diabetes Res Care · 2020Evaluation Study, Research Support, Non-U.S. Gov't
- Accuracy and precision evaluation of seven self-monitoring blood glucose systems.
Kuo CY, Hsu CT, Ho CS, et al. · Diabetes Technol Ther · 2011Comparative Study
- Clinical evaluation of bionime rightest GM310 biosensors with a simplified electrode fabrication for alternative-site blood glucose tests.
Wu MH, Fang MY, Jen LN, et al. · Clin Chem · 2008Research Support, Non-U.S. Gov't
- Assessing the quality of Bionime self-monitoring blood glucose system Rightest GM110: a critical evaluation of interference and ambient circumstances.
Hsu CT, Hsiao HC, Lee MS, et al. · Clin Chim Acta · 2009Evaluation Study
- A consideration of the ethics of brain death--what are the ethical guidelines for physician, family and society in dealing with brain death?
Brooks CM · J UOEH · 1985
Other devices of this type
Also filed under product code NBW.
- On Call Express II Blood Glucose Monitoring SystemACON Laboratories, Inc. · 510(k) 2019
- FreeStyle Precision Neo Blood Glucose Test StripsAbbott Diabetes Care, Inc. · 510(k) 2017
- Accu-Chek Guide Solo diabetes manager blood glucose monitoring systemRoche Diabetes Care GmbH · 510(k) 2023
- POGO Automatic Blood Glucose Monitoring SystemIntuity Medical, Inc. · 510(k) 2018
- iHealth Align Gluco-Monitoring System (BG1)Andon Health Co, Ltd. · 510(k) 2017
- True Metrix Self-Monitoring Blood Glucose SystemNipro Diagnostics, Inc. · 510(k) 2014
- Clever Chek Blood Glucose Monitoring SystemTaidoc Technology Corporation · 510(k) 2009
- Modification to Accu-Chek Active SystemRoche Diagnostics Corp. · 510(k) 2002
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.